US Pharma MarketingSK bioscience links up with Colombia to enable local production of varicella vaccine
SK bioscience links up with Colombia to enable local production of varicella vaccine is a pharma and life sciences industry update from FiercePharma. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Korea’s SK bioscience has signed a technology transfer and manufacturing deal with the Colombian government which will allow the South American nation to produce the company’s chickenpox vaccine SKYVaricella.
Source: FiercePharma